SWAN Genomics: Funding, Investors & Team (Sep 2026)
Swan Genomics is focused on commercialising an innovative new approach to DNA sequencing to deliver more accessible genomics data.
SWAN Genomics has raised $320k across 1 funding round on record, the most recent an undisclosed round of $320k announced in Mar 2026.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
SWAN Genomics Company Profile and Key Stats
Latest funding round on record: Mar 2026.
SWAN Genomics Funding Rounds
SWAN Genomics Founders and Leadership Team
Contact details for the SWAN Genomics team: 1 of 1 has an email address on file, 1 has a LinkedIn profile.
Start 14-day free trial →SWAN Genomics Funding Compared to Other Biotechnology Startups
SWAN Genomics' latest round of $320k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like SWAN Genomics in Biotechnology and Sydney
Companies Similar to SWAN Genomics
AdvanCell is a company that focuses on developing innovative cancer treatments using alpha-emitting isotopes…
The objective of Fluent is to seamlessly integrate humans with AI, improving interaction and communication…
Mesoblast is a developer of biologic products for the broad field of regenerative medicine. Mesoblast's…
Microba Life Sciences Ltd. provides consumers, doctors, and researchers with gut microbiome testing services…
Algenie was founded on a simple realization: algae has the potential to save the earth, but only if it is…
Paradigm Pharmaceuticals is a global biopharmaceutical company driven to discover, develop, and deliver…
Imugene is a publicly-listed biotechnology company with operations in America and Europe,
BiomeBank’s mission is to treat and prevent disease by restoring gut microbial ecology
Telix Pharmaceuticals Ltd is a clinical-stage biotechnology company engaged in developing and commercializing…
Cauldron Ferm is a technique that speeds up the production of precision fermented prototypes to commercial…
HydGene Renewables is developing a biotechnology platform that produces on-site green hydrogen from waste…
OncoRes Medical develops an imaging technology to provide intraoperative information available to surgeons to…
SWAN Genomics Funding FAQs
What does SWAN Genomics do?
Swan Genomics is focused on commercialising an innovative new approach to DNA sequencing to deliver more accessible genomics data.
How much funding has SWAN Genomics raised?
SWAN Genomics has raised $320k across 1 round on record. The most recent is an undisclosed round of $320k announced in Mar 2026.
When did SWAN Genomics last raise funding?
SWAN Genomics' most recent funding round on record is an undisclosed round of $320k, announced in Mar 2026.
Who founded SWAN Genomics?
FundedIQ lists Lawrence Lee (Founder) at SWAN Genomics.
Where is SWAN Genomics headquartered?
SWAN Genomics is based in Sydney, New South Wales, Australia.
How many employees does SWAN Genomics have?
SWAN Genomics is in the 11-50 employee band.
How does SWAN Genomics' funding compare to other Biotechnology startups?
SWAN Genomics' latest round of $320k is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's SWAN Genomics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for SWAN Genomics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.